9. Pain Pathways: Periphery and Sensitization

0.0(0)
studied byStudied by 0 people
0.0(0)
linked notesView linked note
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

17 Terms

1
New cards

Pain (IASP Definition)

An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage, emphasizing its subjective and multidimensional nature.

2
New cards

Nociceptive Pain

Pain resulting from the direct activation of specialized sensory receptors (nociceptors) by noxious (potentially tissue-damaging) stimuli (thermal, mechanical, chemical).

3
New cards

Nociceptors

Free nerve endings of primary afferent neurons that detect and transmit noxious information from the periphery to the central nervous system.

4
New cards

A-delta fibers

Myelinated, fast-conducting fibers responsible for transmitting 'first pain' (sharp, pricking, well-localized sensation).

5
New cards

C fibers

Unmyelinated, slow-conducting fibers responsible for transmitting 'second pain' (dull, aching, throbbing, poorly localized).

6
New cards

Congenital Insensitivity to Pain with Anhidrosis (CIPA)

A rare genetic mutation causing an inability to feel pain and sweat, leading to severe self-inflicted injuries and poor survival rates.

7
New cards

Inflammatory Pain

Pain arising in response to tissue injury, infection, or inflammation, involving chemical mediators that sensitize the pain system (e.g., prostaglandins, bradykinin, cytokines).

8
New cards

Peripheral Sensitization

A process where inflammatory molecules lower the activation threshold of peripheral nociceptors and increase their responsiveness to stimuli.

9
New cards

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

Drugs (e.g., ibuprofen, aspirin) that reduce inflammatory pain by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin production.

10
New cards

Pathological Pain (Chronic Pain)

Persistent or recurrent pain for more than 3 months, beyond expected healing, representing maladaptive plasticity of the nervous system where the pain itself has become a disease entity.

11
New cards

Central Sensitization

A key mechanism in pathological pain characterized by increased excitability of neurons in the spinal cord and brain involved in pain processing, leading to exaggerated responses and expanded receptive fields.

12
New cards

Allodynia

A sensation of pain in response to a normally non-painful (non-noxious) stimulus (e.g., light touch on sunburned skin).

13
New cards

Hyperalgesia

An enhanced or exaggerated sensation of pain in response to a noxious stimulus that would normally cause pain (e.g., a mild cut feeling intensely painful).

14
New cards

Neuropathic Pain

Pain caused by a lesion or disease within the somatosensory nervous system itself (peripheral or central), characterized by burning, shooting, electric shock-like sensations.

15
New cards

Mixed Pain

Pain involving identifiable components of both inflammatory (or nociceptive) and neuropathic pain mechanisms (e.g., chronic lower back pain, cancer pain).

16
New cards

Idiopathic Pain

Pain with an unknown cause, where no specific underlying pathology can be identified despite thorough investigation.

17
New cards

Local Anesthetics (LAs)

Drugs that reversibly block nerve impulse conduction by inhibiting the influx of sodium ions (Na^+) through voltage-gated sodium channels in the neuronal membrane, preventing pain signals from reaching the brain.